vs
Side-by-side financial comparison of NOODLES & Co (NDLS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
NOODLES & Co is the larger business by last-quarter revenue ($122.1M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -4.1%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-2.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.2%).
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NDLS vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $122.1M | $75.5M |
| Net Profit | $-9.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -5.2% | 22.7% |
| Net Margin | -7.5% | — |
| Revenue YoY | -4.1% | 27.7% |
| Net Profit YoY | 32.8% | — |
| EPS (diluted) | $-0.20 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $122.1M | $54.5M | ||
| Q2 25 | $123.8M | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | $122.8M | $59.1M | ||
| Q3 24 | $127.4M | $80.5M | ||
| Q2 24 | $121.4M | $47.1M | ||
| Q1 24 | $124.3M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-9.2M | $8.8M | ||
| Q2 25 | $-9.1M | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $-6.8M | — | ||
| Q3 24 | $-13.6M | $20.3M | ||
| Q2 24 | $-6.1M | $-4.5M | ||
| Q1 24 | $-6.1M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -5.2% | 17.6% | ||
| Q2 25 | -5.2% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | -3.9% | 22.6% | ||
| Q3 24 | -9.0% | 27.4% | ||
| Q2 24 | -3.4% | -4.6% | ||
| Q1 24 | -3.7% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -7.5% | 16.2% | ||
| Q2 25 | -7.3% | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | -5.5% | — | ||
| Q3 24 | -10.7% | 25.2% | ||
| Q2 24 | -5.1% | -9.6% | ||
| Q1 24 | -4.9% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-0.20 | $0.17 | ||
| Q2 25 | $-0.20 | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | $-0.15 | $0.40 | ||
| Q3 24 | $-0.30 | $0.41 | ||
| Q2 24 | $-0.14 | $-0.09 | ||
| Q1 24 | $-1.64 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.7M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $-38.9M | $130.3M |
| Total Assets | $280.6M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $4.7M | $94.4M | ||
| Q2 25 | $1.4M | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | $3.3M | $101.0M | ||
| Q3 24 | $1.8M | $96.7M | ||
| Q2 24 | $1.3M | $96.8M | ||
| Q1 24 | $3.0M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $-38.9M | $115.3M | ||
| Q2 25 | $-13.9M | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $3.7M | $92.1M | ||
| Q3 24 | $9.6M | $71.1M | ||
| Q2 24 | $21.9M | $48.5M | ||
| Q1 24 | $27.2M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $280.6M | $202.9M | ||
| Q2 25 | $319.4M | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | $340.5M | $213.3M | ||
| Q3 24 | $346.3M | $220.7M | ||
| Q2 24 | $360.4M | $205.0M | ||
| Q1 24 | $368.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $4.3M | $14.4M |
| Free Cash FlowOCF − Capex | $-2.8M | $14.4M |
| FCF MarginFCF / Revenue | -2.3% | 19.1% |
| Capex IntensityCapex / Revenue | 5.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $4.3M | $9.7M | ||
| Q2 25 | $4.0M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $5.8M | $15.6M | ||
| Q3 24 | $4.7M | $11.0M | ||
| Q2 24 | $7.0M | $1.0M | ||
| Q1 24 | $164.0K | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $-2.8M | $9.7M | ||
| Q2 25 | $1.1M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-1.3M | $15.6M | ||
| Q3 24 | $-4.5M | $11.0M | ||
| Q2 24 | $-1.6M | $1.0M | ||
| Q1 24 | $-15.2M | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | -2.3% | 17.7% | ||
| Q2 25 | 0.9% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -1.1% | 26.4% | ||
| Q3 24 | -3.5% | 13.7% | ||
| Q2 24 | -1.4% | 2.1% | ||
| Q1 24 | -12.2% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 5.8% | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 7.2% | 0.0% | ||
| Q2 24 | 7.1% | 0.0% | ||
| Q1 24 | 12.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
PBYI
Segment breakdown not available.